;PMID: 1281274
;source_file_1009.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..37] = [t:0..37]
;1)sentence:[e:43..139] = [t:43..139]
;2)section:[e:143..190] = [t:143..190]
;3)section:[e:194..246] = [t:194..246]
;4)sentence:[e:250..486] = [t:250..486]
;5)sentence:[e:487..756] = [t:487..756]
;6)sentence:[e:757..949] = [t:757..949]
;7)sentence:[e:950..1316] = [t:950..1316]
;8)sentence:[e:1318..1555] = [t:1318..1555]
;9)sentence:[e:1556..1766] = [t:1556..1766]
;10)sentence:[e:1767..2028] = [t:1767..2028]
;11)sentence:[e:2029..2197] = [t:2029..2197]
;12)sentence:[e:2198..2321] = [t:2198..2321]
;13)section:[e:2325..2369] = [t:2325..2368]
;Sentence Matching Errors
;ERROR_Section end mismatch[e:2325..2369][t:2325..2368]
;Token/POS Errors
;ERROR_Token in entity file but not tree[2368..2369] ]

;section 0 Span:0..37
;Mutat Res. 1992 Dec 16;284(2):233-41.
(SEC
  (FRAG (NNP:[0..5] Mutat) (NNP:[6..9] Res) (.:[9..10] .) (CD:[11..15] 1992)
        (NNP:[16..19] Dec) (CC:[20..27] 16;284-LRB-) (CD:[27..28] 2)
        (-RRB-:[28..29] -RRB-) (CD:[29..33] :233) (::[33..34] -)
        (CD:[34..36] 41) (.:[36..37] .)))

;sentence 1 Span:43..139
;Rat pulmonary microsomal cytochrome P-450 enzymes involved in the activation
;of  procarcinogens.
;[68..92]:cyp450:"cytochrome P-450 enzymes"
;[124..138]:substance:"procarcinogens"
(SENT
  (NP-HLN
    (NP (NN:[43..46] Rat) (JJ:[47..56] pulmonary) (JJ:[57..67] microsomal)
      
      (NML (NN:[68..78] cytochrome) (NN:[79..84] P-450))
      (NNS:[85..92] enzymes))
    (VP (VBN:[93..101] involved)
      (NP (-NONE-:[101..101] *))
      (PP-CLR (IN:[102..104] in)
        (NP
          (NP (DT:[105..108] the) (NN:[109..119] activation))
          (PP (IN:[120..122] of)
            (NP (NNS:[124..138] procarcinogens))))))
    (.:[138..139] .)))

;section 2 Span:143..190
;Shimada T, Yamazaki H, Mimura M, Guengerich FP.
(SEC
  (FRAG (NNP:[143..150] Shimada) (NNP:[151..152] T) (,:[152..153] ,)
        (NNP:[154..162] Yamazaki) (NNP:[163..164] H) (,:[164..165] ,)
        (NNP:[166..172] Mimura) (NNP:[173..174] M) (,:[174..175] ,)
        (NNP:[176..186] Guengerich) (NNP:[187..189] FP) (.:[189..190] .)))

;section 3 Span:194..246
;Osaka Prefectural Institute of Public Health, Japan.
(SEC
  (FRAG (NNP:[194..199] Osaka) (NNP:[200..211] Prefectural)
        (NNP:[212..221] Institute) (IN:[222..224] of) (NNP:[225..231] Public)
        (NNP:[232..238] Health) (,:[238..239] ,) (NNP:[240..245] Japan)
        (.:[245..246] .)))

;sentence 4 Span:250..486
;Rat lung microsomal cytochrome P-450 (P-450) enzymes have been characterized 
;with regard to their catalytic specificities towards activation of several 
;procarcinogens to genotoxic metabolites in Salmonella typhimurium 
;TA1535/pSK1002.
;[270..302]:cyp450:"cytochrome P-450 (P-450) enzymes"
;[404..418]:substance:"procarcinogens"
;[432..443]:substance:"metabolites"
(SENT
  (S
    (NP-SBJ-1 (NN:[250..253] Rat) (NN:[254..258] lung)
              (JJ:[259..269] microsomal)
      
      (NML
        (NML (NN:[270..280] cytochrome) (NN:[281..286] P-450))
        (NML (-LRB-:[287..288] -LRB-) (CD:[288..293] P-450)
             (-RRB-:[293..294] -RRB-)))
      (NNS:[295..302] enzymes))
    (VP (VB:[303..307] have)
      (VP (VBN:[308..312] been)
        (VP (VBN:[313..326] characterized)
          (NP-1 (-NONE-:[326..326] *))
          (PP (IN:[328..332] with)
            (NP
              (NP (NN:[333..339] regard))
              (PP (TO:[340..342] to)
                (NP
                  (NP (PRP$:[343..348] their) (JJ:[349..358] catalytic)
                      (NNS:[359..372] specificities))
                  (PP (IN:[373..380] towards)
                    (NP
                      (NP (NN:[381..391] activation))
                      (PP (IN:[392..394] of)
                        (NP
                          (NP (JJ:[395..402] several)
                              (NNS:[404..418] procarcinogens))
                          (PP (TO:[419..421] to)
                            (NP (JJ:[422..431] genotoxic)
                                (NNS:[432..443] metabolites)))))
                      (PP (IN:[444..446] in)
                        (NP (NNP:[447..457] Salmonella)
                            (NNP:[458..469] typhimurium) (NN:[471..477] TA1535)
                            (SYM:[477..478] /) (NN:[478..485] pSK1002))))))))))))
    (.:[485..486] .)))

;sentence 5 Span:487..756
;We first examined the roles of rat liver microsomal P-450  enzymes in the
;activation of benzo[a]pyrene and its 7,8-diol enantiomers to  genotoxic
;products, and found that P-450 1A1 is a major catalyst for the  activation of
;these potential procarcinogens in rat livers.
;[539..553]:cyp450:"P-450  enzymes"
;[575..589]:substance:"benzo[a]pyrene"
;[598..618]:substance:"7,8-diol enantiomers"
;[658..667]:cyp450:"P-450 1A1"
;[727..741]:substance:"procarcinogens"
(SENT
  (S
    (NP-SBJ (PRP:[487..489] We))
    (VP
      (VP
        (ADVP (RB:[490..495] first))
        (VBD:[496..504] examined)
        (NP
          (NP (DT:[505..508] the) (NNS:[509..514] roles))
          (PP (IN:[515..517] of)
            (NP (NN:[518..521] rat) (NN:[522..527] liver)
                (JJ:[528..538] microsomal)
               (NN:[539..544] P-450) (NNS:[546..553] enzymes))))
        (PP (IN:[554..556] in)
          (NP
            (NP (DT:[557..560] the) (NN:[561..571] activation))
            (PP (IN:[572..574] of)
              (NP
                (NP (NN:[575..589] benzo-LSB-a-RSB-pyrene))
                (CC:[590..593] and)
                (NP (PRP$:[594..597] its)
                   (NN:[598..606] 7,8-diol) (NNS:[607..618] enantiomers))))
            (PP (TO:[619..621] to)
              (NP (JJ:[623..632] genotoxic) (NNS:[633..641] products))))))
      (,:[641..642] ,) (CC:[643..646] and)
      (VP (VBD:[647..652] found)
        (SBAR (IN:[653..657] that)
          (S
            (NP-SBJ (NN:[658..663] P-450) (NN:[664..667] 1A1))
            (VP (IN:[668..670] is)
              (NP-PRD
                (NP (DT:[671..672] a) (JJ:[673..678] major)
                    (NN:[679..687] catalyst))
                (PP (IN:[688..691] for)
                  (NP
                    (NP (DT:[692..695] the) (NN:[697..707] activation))
                    (PP (IN:[708..710] of)
                      (NP (DT:[711..716] these) (JJ:[717..726] potential)
                          (NNS:[727..741] procarcinogens)))
                    (PP-LOC (IN:[742..744] in)
                      (NP (NN:[745..748] rat) (NNS:[749..755] livers)))))))))))
    (.:[755..756] .)))

;sentence 6 Span:757..949
;Using lung  microsomes isolated from rats treated with various P-450 inducers
;we obtained  evidence that at least three P-450 enzymes are involved in the
;activation of  several procarcinogens.
;[820..825]:cyp450:"P-450"
;[826..834]:substance:"inducers"
;[877..890]:cyp450:"P-450 enzymes"
;[934..948]:substance:"procarcinogens"
(SENT
  (S
    (S-MNR
      (NP-SBJ (-NONE-:[757..757] *))
      (VP (VBG:[757..762] Using)
        (NP
          (NP (NN:[763..767] lung) (NNS:[769..779] microsomes))
          (VP (VBN:[780..788] isolated)
            (NP (-NONE-:[788..788] *))
            (PP (IN:[789..793] from)
              (NP
                (NP (NNS:[794..798] rats))
                (VP (VBN:[799..806] treated)
                  (NP (-NONE-:[806..806] *))
                  (PP (IN:[807..811] with)
                    (NP (JJ:[812..819] various) (NN:[820..825] P-450)
                        (NNS:[826..834] inducers))))))))))
    (NP-SBJ (PRP:[835..837] we))
    (VP (VBD:[838..846] obtained)
      (NP (NN:[848..856] evidence)
        (SBAR (IN:[857..861] that)
          (S
            (NP-SBJ-1
              (QP (IN:[862..864] at) (JJS:[865..870] least)
                  (CD:[871..876] three))
               (NN:[877..882] P-450) (NNS:[883..890] enzymes))
            (VP (VBP:[891..894] are)
              (VP (VBN:[895..903] involved)
                (NP-1 (-NONE-:[903..903] *))
                (PP-CLR (IN:[904..906] in)
                  (NP
                    (NP (DT:[907..910] the) (NN:[911..921] activation))
                    (PP (IN:[922..924] of)
                      (NP (JJ:[926..933] several)
                          (NNS:[934..948] procarcinogens)))))))))))
    (.:[948..949] .)))

;sentence 7 Span:950..1316
;Immunoinhibition studies support the view that  benzo[a]pyrene and its
;7,8-diol derivatives, other dihydrodiol derivatives of  polycyclic aromatic
;hydrocarbons, and 3-amino-1-methyl-5H-pyrido[4,3-b]indole  are activated to
;genotoxins mainly by rat P-450 1A1, which is inducible in rat  lungs by
;5,6-benzoflavone and the polychlorinated biphenyl mixture Aroclor 1254.
;[998..1012]:substance:"benzo[a]pyrene"
;[1021..1041]:substance:"7,8-diol derivatives"
;[1049..1072]:substance:"dihydrodiol derivatives"
;[1077..1109]:substance:"polycyclic aromatic hydrocarbons"
;[1115..1154]:substance:"3-amino-1-methyl-5H-pyrido[4,3-b]indole"
;[1173..1183]:substance:"genotoxins"
;[1198..1207]:cyp450:"P-450 1A1"
;[1245..1261]:substance:"5,6-benzoflavone"
;[1286..1294]:substance:"biphenyl"
;[1303..1315]:substance:"Aroclor 1254"
(SENT
  (S
    (NP-SBJ (NN:[950..966] Immunoinhibition) (NNS:[967..974] studies))
    (VP (VBP:[975..982] support)
      (NP (DT:[983..986] the) (NN:[987..991] view)
        (SBAR (IN:[992..996] that)
          (S
            (NP-SBJ-2
              (NP
                (NP (NN:[998..1012] benzo-LSB-a-RSB-pyrene))
                (CC:[1013..1016] and)
                (NP (PRP$:[1017..1020] its)
                   (NN:[1021..1029] 7,8-diol) (NNS:[1030..1041] derivatives)))
              (,:[1041..1042] ,)
              (NP
                (NP (JJ:[1043..1048] other)
                   (NN:[1049..1060] dihydrodiol) (NNS:[1061..1072] derivatives))
                (PP (IN:[1073..1075] of)
                  (NP (JJ:[1077..1087] polycyclic) (JJ:[1088..1096] aromatic)
                      (NNS:[1097..1109] hydrocarbons))))
              (,:[1109..1110] ,) (CC:[1111..1114] and)
              (NP
                  (NN:[1115..1154] 3-amino-1-methyl-5H-pyrido-LSB-4,3-b-RSB-indole)))
            (VP (VBP:[1156..1159] are)
              (VP (VBN:[1160..1169] activated)
                (NP-2 (-NONE-:[1169..1169] *))
                (PP (TO:[1170..1172] to)
                  (NP (NNS:[1173..1183] genotoxins)))
                (PP
                  (ADVP (RB:[1184..1190] mainly))
                  (IN:[1191..1193] by)
                  (NP-LGS
                    (NP (NN:[1194..1197] rat)
                       (NN:[1198..1203] P-450) (NN:[1204..1207] 1A1))
                    (,:[1207..1208] ,)
                    (SBAR
                      (WHNP-1 (WDT:[1209..1214] which))
                      (S
                        (NP-SBJ-1 (-NONE-:[1214..1214] *T*))
                        (VP (VBZ:[1215..1217] is)
                          (ADJP-PRD (JJ:[1218..1227] inducible)
                            (PP-3 (-NONE-:[1227..1227] *ICH*)))
                          (PP-LOC (IN:[1228..1230] in)
                            (NP (NN:[1231..1234] rat) (NNS:[1236..1241] lungs)))
                          (PP-3 (IN:[1242..1244] by)
                            (NP
                              (NP (NN:[1245..1261] 5,6-benzoflavone))
                              (CC:[1262..1265] and)
                              (NP
                                (NP (DT:[1266..1269] the)
                                  (NML (VBN:[1270..1285] polychlorinated)
                                       (NN:[1286..1294] biphenyl))
                                  (NN:[1295..1302] mixture))
                                (NP (NN:[1303..1310] Aroclor)
                                    (CD:[1311..1315] 1254))))))))))))))))
    (.:[1315..1316] .)))

;sentence 8 Span:1318..1555
;Activation of 2-amino-3,5-dimethylimidazo[4,5-f]quinoline and 
;2-amino-3-methylimidazo[4,5-f]quinoline may be catalyzed by another P-450
;enzyme  because the activities were not induced by treatment with
;5,6-benzoflavone or  Aroclor 1254.
;[1332..1375]:substance:"2-amino-3,5-dimethylimidazo[4,5-f]quinoline"
;[1381..1420]:substance:"2-amino-3-methylimidazo[4,5-f]quinoline"
;[1449..1461]:cyp450:"P-450 enzyme"
;[1521..1537]:substance:"5,6-benzoflavone"
;[1542..1554]:substance:"Aroclor 1254"
(SENT
  (S
    (NP-SBJ-2
      (NP (NN:[1318..1328] Activation))
      (PP (IN:[1329..1331] of)
        (NP
            (NN:[1332..1375] 2-amino-3,5-dimethylimidazo-LSB-4,5-f-RSB-quinoline)
            (CC:[1376..1379] and)
            (NN:[1381..1420] 2-amino-3-methylimidazo-LSB-4,5-f-RSB-quinoline))))
    (VP (MD:[1421..1424] may)
      (VP (VB:[1425..1427] be)
        (VP (VBN:[1428..1437] catalyzed)
          (NP-2 (-NONE-:[1437..1437] *))
          (PP (IN:[1438..1440] by)
            (NP-LGS (DT:[1441..1448] another)
               (NN:[1449..1454] P-450) (NN:[1455..1461] enzyme)))
          (SBAR-PRP (IN:[1463..1470] because)
            (S
              (NP-SBJ-1 (DT:[1471..1474] the) (NNS:[1475..1485] activities))
              (VP (VBD:[1486..1490] were) (RB:[1491..1494] not)
                (VP (VBN:[1495..1502] induced)
                  (NP-1 (-NONE-:[1502..1502] *))
                  (PP (IN:[1503..1505] by)
                    (NP-LGS
                      (NP (NN:[1506..1515] treatment))
                      (PP (IN:[1516..1520] with)
                        (NP
                          (NP (NN:[1521..1537] 5,6-benzoflavone))
                          (CC:[1538..1540] or)
                          (NP (NN:[1542..1549] Aroclor) (CD:[1550..1554] 1254)))))))))))))
    (.:[1554..1555] .)))

;sentence 9 Span:1556..1766
;The observation that both activities were inhibited by antibodies  raised
;against P-450 1A2 and by 7,8-benzoflavone suggests a role for an enzyme  of
;P-450 1A family, probably P-450 1A2, in rat lung microsomes.
;[1611..1621]:substance:"antibodies"
;[1638..1647]:cyp450:"P-450 1A2"
;[1655..1671]:substance:"7,8-benzoflavone"
;[1695..1701]:cyp450:"enzyme"
;[1706..1714]:cyp450:"P-450 1A"
;[1732..1741]:cyp450:"P-450 1A2"
(SENT
  (S
    (NP-SBJ (DT:[1556..1559] The) (NN:[1560..1571] observation)
      (SBAR (IN:[1572..1576] that)
        (S
          (NP-SBJ-1 (DT:[1577..1581] both) (NNS:[1582..1592] activities))
          (VP (VBD:[1593..1597] were)
            (VP (VBN:[1598..1607] inhibited)
              (NP-1 (-NONE-:[1607..1607] *))
              (PP
                (PP (IN:[1608..1610] by)
                  (NP-LGS
                    (NP (NNS:[1611..1621] antibodies))
                    (VP (VBN:[1623..1629] raised)
                      (NP (-NONE-:[1629..1629] *))
                      (PP (IN:[1630..1637] against)
                        (NP (NN:[1638..1643] P-450) (NN:[1644..1647] 1A2))))))
                (CC:[1648..1651] and)
                (PP (IN:[1652..1654] by)
                  (NP-LGS (NN:[1655..1671] 7,8-benzoflavone)))))))))
    (VP (VBZ:[1672..1680] suggests)
      (NP
        (NP (DT:[1681..1682] a) (NN:[1683..1687] role))
        (PP (IN:[1688..1691] for)
          (NP
            (NP
              (NP (DT:[1692..1694] an) (NN:[1695..1701] enzyme))
              (PP (IN:[1703..1705] of)
                (NP
                  (NML (NN:[1706..1711] P-450) (NN:[1712..1714] 1A))
                  (NN:[1715..1721] family))))
            (,:[1721..1722] ,)
            (NP
              (ADVP (RB:[1723..1731] probably))
               (NN:[1732..1737] P-450) (NN:[1738..1741] 1A2)))))
      (,:[1741..1742] ,)
      (PP-LOC (IN:[1743..1745] in)
        (NP (NN:[1746..1749] rat) (NN:[1750..1754] lung)
            (NNS:[1755..1765] microsomes))))
    (.:[1765..1766] .)))

;sentence 10 Span:1767..2028
;The activation  of aflatoxin B1 and sterigmatocystin appears to be catalyzed
;by other P-450  enzyme(s) rather than the P-450 1A family as judged by the
;different responses  of activities to the P-450 inducers and the specific
;antibodies in rat lung  microsomes.
;[1786..1798]:substance:"aflatoxin B1"
;[1803..1819]:substance:"sterigmatocystin"
;[1853..1869]:cyp450:"P-450  enzyme(s)"
;[1886..1894]:cyp450:"P-450 1A"
;[1961..1966]:cyp450:"P-450"
;[1967..1975]:substance:"inducers"
;[1993..2003]:substance:"antibodies"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[1767..1770] The) (NN:[1771..1781] activation))
      (PP (IN:[1783..1785] of)
        (NP
          (NP (NN:[1786..1795] aflatoxin) (NN:[1796..1798] B1))
          (CC:[1799..1802] and)
          (NP (NN:[1803..1819] sterigmatocystin)))))
    (VP (VBZ:[1820..1827] appears)
      (S
        (NP-SBJ-1 (-NONE-:[1827..1827] *))
        (VP (TO:[1828..1830] to)
          (VP (VB:[1831..1833] be)
            (VP (VBN:[1834..1843] catalyzed)
              (NP-1 (-NONE-:[1843..1843] *))
              (PP (IN:[1844..1846] by)
                (NP-LGS
                  (NP (JJ:[1847..1852] other)
                     (NN:[1853..1858] P-450)
                     (NNS:[1860..1869] enzyme-LRB-s-RRB-))
                  (PP (RB:[1870..1876] rather) (IN:[1877..1881] than)
                    (NP (DT:[1882..1885] the)
                       (NN:[1886..1891] P-450) (NN:[1892..1894] 1A)
                      (NN:[1895..1901] family)))))
              (SBAR-ADV (IN:[1902..1904] as)
                (S
                  (NP-SBJ-2 (-NONE-:[1904..1904] *))
                  (VP (VBN:[1905..1911] judged)
                    (NP-2 (-NONE-:[1911..1911] *))
                    (PP-MNR (IN:[1912..1914] by)
                      (NP
                        (NP (DT:[1915..1918] the) (JJ:[1919..1928] different)
                            (NNS:[1929..1938] responses))
                        (PP (IN:[1940..1942] of)
                          (NP (NNS:[1943..1953] activities)))
                        (PP (TO:[1954..1956] to)
                          (NP
                            (NP
                              (NP (DT:[1957..1960] the) (NN:[1961..1966] P-450)
                                  (NNS:[1967..1975] inducers))
                              (CC:[1976..1979] and)
                              (NP (DT:[1980..1983] the)
                                  (JJ:[1984..1992] specific)
                                  (NN:[1993..2003] antibodies)))
                            (PP-LOC (IN:[2004..2006] in)
                              (NP (NN:[2007..2010] rat) (NN:[2011..2015] lung)
                                  (NNS:[2017..2027] microsomes)))))))))))))))
    (.:[2027..2028] .)))

;sentence 11 Span:2029..2197
;Interestingly, lung microsomal activation of several procarcinogens  was
;found to be suppressed in rats treated with isosafrole and pregnenolone 16 
;alpha-carbonitrile.
;[2082..2096]:substance:"procarcinogens"
;[2146..2156]:substance:"isosafrole"
;[2161..2196]:substance:"pregnenolone 16  alpha-carbonitrile"
(SENT
  (S
    (ADVP (RB:[2029..2042] Interestingly))
    (,:[2042..2043] ,)
    (NP-SBJ-1
      (NP (NN:[2044..2048] lung) (JJ:[2049..2059] microsomal)
          (NN:[2060..2070] activation))
      (PP (IN:[2071..2073] of)
        (NP (JJ:[2074..2081] several) (NNS:[2082..2096] procarcinogens))))
    (VP (VBD:[2098..2101] was)
      (VP (VBN:[2102..2107] found)
        (S
          (NP-SBJ-1 (-NONE-:[2107..2107] *))
          (VP (TO:[2108..2110] to)
            (VP (VB:[2111..2113] be)
              (VP (VBN:[2114..2124] suppressed)
                (NP-1 (-NONE-:[2124..2124] *))
                (PP-LOC (IN:[2125..2127] in)
                  (NP
                    (NP (NNS:[2128..2132] rats))
                    (VP (VBN:[2133..2140] treated)
                      (NP (-NONE-:[2140..2140] *))
                      (PP-MNR (IN:[2141..2145] with)
                        (NP
                          (NP (NN:[2146..2156] isosafrole))
                          (CC:[2157..2160] and)
                          (NP (NN:[2161..2173] pregnenolone)
                              (CD:[2174..2176] 16)
                              (NN:[2178..2196] alpha-carbonitrile)))))))))))))
    (.:[2196..2197] .)))

;sentence 12 Span:2198..2321
;Thus, the results support the roles of different P-450  enzymes in the
;activation of procarcinogens in rat lung microsomes.
;[2247..2261]:cyp450:"P-450  enzymes"
;[2283..2297]:substance:"procarcinogens"
(SENT
  (S
    (ADVP (RB:[2198..2202] Thus))
    (,:[2202..2203] ,)
    (NP-SBJ (DT:[2204..2207] the) (NNS:[2208..2215] results))
    (VP (IN:[2216..2223] support)
      (NP
        (NP (DT:[2224..2227] the) (NNS:[2228..2233] roles))
        (PP (IN:[2234..2236] of)
          (NP (JJ:[2237..2246] different)
             (NN:[2247..2252] P-450) (NNS:[2254..2261] enzymes)))
        (PP (IN:[2262..2264] in)
          (NP
            (NP (DT:[2265..2268] the) (NN:[2269..2279] activation))
            (PP (IN:[2280..2282] of)
              (NP (NNS:[2283..2297] procarcinogens)))
            (PP-LOC (IN:[2298..2300] in)
              (NP (NN:[2301..2304] rat) (NN:[2305..2309] lung)
                  (NNS:[2310..2320] microsomes)))))))
    (.:[2320..2321] .)))

;section 13 Span:2325..2368
;PMID: 1281274 [PubMed - indexed for MEDLINE
(SEC
  (FRAG (NNP:[2325..2329] PMID) (::[2329..2330] :) (CD:[2331..2338] 1281274)
        (-LRB-:[2339..2340] -LSB-) (NNP:[2340..2346] PubMed) (::[2347..2348] -)
        (VBN:[2349..2356] indexed) (IN:[2357..2360] for)
        (NNP:[2361..2368] MEDLINE)))
;ERROR_Orphan Text from EOF Tree File[2368..EOF] ]

(ORPH -RSB-)
